Last update 25 May 2026

EGFR L858R x PLK1

Basic Info

Related Targets
EGFR L858RPLK1

Related

1
Clinical Trials associated with EGFR L858R x PLK1
NCT01206816
/ CompletedPhase 1
An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 in Combination With Oral BIBW 2992 in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit
100 Clinical Results associated with EGFR L858R x PLK1
Login to view more data
100 Translational Medicine associated with EGFR L858R x PLK1
Login to view more data
0 Patents (Medical) associated with EGFR L858R x PLK1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free